KRAS and neoplasm: analyzing tumor metabolomes from genetically engineered mouse models and gene expression profiling of human tumors co-mutated in KRAS and LKB1 or p53, outlined a dependency of KRAS/LKB1 mutated cells on the hexosamine biosynthesis pathway (114).